Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications
Tóm tắt
There is evidence for increased levels of circulating reactive oxygen species (ROS) in diabetics, as indirectly inferred by the findings of increased lipid peroxidation and decreased antioxidant status. Direct measurements of intracellular generation of ROS using fluorescent dyes also demonstrate an association of oxidative stress with diabetes. Although phenolic compounds attenuate oxidative stress-related tissue damage, there are concerns over toxicity of synthetic phenolic antioxidants and this has considerably stimulated interest in investigating the role of natural phenolics in medicinal applications. Curcumin (the primary active principle in turmeric,Curcuma longa Linn.) has been claimed to represent a potential antioxidant and antiinflammatory agent with phytonutrient and bioprotective properties. However there are lack of molecular studies to demonstrate its cellular action and potential molecular targets. In this study the antioxidant effect of curcumin as a function of changes in cellular ROS generation was tested. Our results clearly demonstrate that curcumin abolished both phorbol-12 myristate-13 acetate (PMA) and thapsigargin-induced ROS generation in cells from control and diabetic subjects. The pattern of these ROS inhibitory effects as a function of dose-dependency suggests that curcumin mechanistically interferes with protein kinase C (PKC) and calcium regulation. Simultaneous measurements of ROS and Ca2+ influx suggest that a rise in cytosolic Ca2+ may be a trigger for increased ROS generation. We suggest that the antioxidant and antiangeogenic actions of curcumin, as a mechanism of inhibition of Ca2+ entry and PKC activity, should be further exploited to develop suitable and novel drugs for the treatment of diabetic retinopathy and other diabetic complications.
Tài liệu tham khảo
Abe Y, Hashimoto S and Horie T 1999 Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages;Pharmacol. Res. 39 41–47.
Aggarwal B B, Kumar A and Bharti A C 2003 Anticancer potential of curcumin: preclinical and clinical studies;Anticancer Res. 23 363–398
Armstrong D, Ueda T, Aljada A, Browne R, Fukuda S, Spengler R, Chou R, Hartnett M, Buch P, Dandona P, Sasisekharan R and Dorey C K 1998 Lipid hydroperoxide stimulates retinal neovascularisation in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor;Angiogenesis 2 93–104
Balasubramanyam M, Kimura M, Aviv A and Gardner J P 1993 Kinetics of calcium transport across the lymphocyte plasma membrane;Am. J. Physiol. 265 C321-C327
Balasubramanyam M, Balaji A, Subashini B and Mohan V 2001 Evidence for mechanistic alterations of Ca2+ homeostasis in type 2 diabetes mellitus;Int. J. Exp. Diabetes Res. 1 275–287
Balasubramanyam M and Mohan V 2002 The need for high throughput screening of herbal medicine with special reference to diabetes mellitus; inBiodiversity (monitoring, management, conservation and enhancement) (eds) R Ramamurthi and G Bali (New Delhi: APH Publishing Corp.) pp 57–74
Balasubramanyam M, Premanand C, Sampathkumar R and Mohan V 2002 Rosiglitazone and troglitazone protect against Oxidative Stress: Possible role of Store-Operated Ca2+ Fluxes;Diabetes (Suppl. 2)54 A449
Baynes J W 1991 Role of oxidative stress in development of complications in diabetes;Diabetes 40 405–412
Bierhaus A, Zhang Y, Quehenberger P, Luther T, Haase M, Muller M, Mackman N, Ziegler R and Nawroth P P 1997 The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B;Thromb. Haemost. 77 772–782
Bilmen J G, Khan S Z, Javed M H and Michelangeli F 2001 Inhibition of SERCA Ca2+ pumps by curcumin;Eur. J. Biochem. 268 6318–6327
Bonnefont-Rousselot D 2002 Glucose and reactive oxygen species;Curr. Opin. Clin. Nutr. Metab. Care 5 561–568
Brownlee M 2001 Biochemistry and molecular cell biology of diabetic complications;Nature (London) 414 813–820
Ceriello A 2003 New insights on oxidative stress and diabetic complications may lead to a “Causal” antioxidant therapy;Diabetes Care 26 1589–1596
Chainani-Wu N 2003 Safety and anti-inflammatory activity of curcumin: A component of turmeric (Curcuma longa);J. Altern. Complement. Med. 9 161–168
Chen Y C, Kuo T C, Lin-Shiau S Y and Lin J K 1996 Induction of HSP70 gene expression by modulation of Ca2+ ion and cellular p53 protein by curcumin in colorectal carcinoma cells;Mol. Carcinog. 17 224–234
Chen H W and Huang H C 1998 Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells;Br. J. Pharmacol. 124 1029–1040
Cheng A L, Hsu C H, Lin J K, Hsu M M, Ho Y F, Shen T S, Ko J Y, Lin J T, Lin B R, Ming-Shiang W, Yu H S, Jee S H, Chen G S, Chen T M, Chen C A, Lai M K, Pu Y S, Pan M H, Wang Y J, Tsai C C and Hsieh C Y 2001 Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions;Anticancer Res. 21 2895–2900
Dyer J L, Khan S Z, Bilmen J G, Hawtin S R, Wheatley M, Javed M U and Michelangeli F 2002 Curcumin: a new cellpermeant inhibitor of the inositol 1,4,5-trisphosphate receptor;Cell Calcium 31 45–52
Frank R N 2002 Potential new medical therapies for Diabetic Retinopathy: Protein Kinase C inhibitors;Am. J. Ophthalmol. 133 693–698
Gopalakrishna R and Jaken S 2000 Protein Kinase C signalling and oxidative stress;Free Radic. Biol. Med. 28 1349–1361
Kowluru R A 2001 Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated;Acta Diabetol. 38 179–185
Lee T S, Saltsman K A, Ohashi H and King G L 1989 Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications;Proc. Natl. Acad. Sci. USA 86 5141–5145
Liu J Y, Lin S J and Lin J K 1993 Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells;Carcinogenesis 14 857–861
Martens F M, Visseren F L, Lemay J, de Koning E J and Rabelink T J 2002 Metabolic and additional vascular effects of thioazolidinediones;Drugs 62 1463–1480
Mercuri F, Quagliaro L and Ceriello A 2000 Oxidative stress evaluation in diabetes;Diabetes Technol. Ther. 2 589–600
Ohno S and Nishizuka Y 2002 Protein kinase C Isotypes and their specific functions: Prologue;J. Biochem. 132 509–511
Okamoto T, Yamagishi S, Inagaki Y, Amano S, Koga K, Abe R, Takeuchi M, Ohno S, Yoshimura A and Makita Z 2002 Angiogenesis induced by advanced glycation end products and its prevention by cerivastin;FASEB J. 16 1928–1930
Palmer H J and Paulson K E 1997 Reactive oxygen species and antioxidants in signal Transduction and gene expression;Nutr. Rev. 55 353–361
Piwocka K, Zablocki K, Wieckowski M R, Skierski J, Feiga I, Szopa J, Derla N, Wojtczak L and Sikora E 1999 A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells;Exp. Cell. Res. 249 299–307
Rosen P, Nawroth P P, King G, Moller W, Tritschler H-J and Packer L 2001 The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society;Diabetes Metab. Res. Rev. 17 189–212
Shah B H, Nawaz Z, Pertani S A, Roomi A, Mahmood H, Saeed S A and Gilani A H 1999 Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor-and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signalling;Biochem. Pharmacol. 58 1167–1172
Srinivasan K R 1953 Chromatographic study of the curcuminoids inCurcuma longa;J. Pharma. Pharmacol. 5 448
Srivastava K C, Bordia A and Verma S K 1995 Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets;Protaglandins Leukot. Essent. Fatty Acids 52 223–227
Sundaresan M, Yu Z X, Ferrans V J, Irani K and Finkel T 1995 Requirements for generation of H2O2 for PDGF signal transduction;Science 270 296–299
Thastrup O, Cullen P J, Droback B K, Humley M R and Dawson A P 1990 Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase;Proc. Natl. Acad. Sci. USA 87 2466–2470
Xu J, Fu Y and Chen A 2003 Activation of peroxisome proliferator-activated receptor-(gamma) contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth;Am. J. Physiol. 285 G20-G30
Zhang F, Altorki N K, Mestre J R, Subbaramaiah K and Dannenberg A J 1999 Curcumin inhibits cyclooxygenase-2 transrcription in bile acid-and phorbol ester-treated human gastrointestinal epithelial cells;Carcinogenesis 20 445–451